CHMP Recommended Granting Marketing Authorization For Elahere For The Treatment Of Adults With Ovarian Cancer, Fallopian Tube Cancer, Or Primary Peritoneal Cancer
CHMP Recommended Granting Marketing Authorization For Elahere For The Treatment Of Adults With Ovarian Cancer, Fallopian Tube Cancer, Or Primary Peritoneal Cancer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.